High CV risk in young people is a 'delayed' crisis

Published Date: 08 Mar 2023

Cardiovascular disease is "unacceptably" high and increasing among American adults ages 20 to 44, requiring aggressive prevention.

Read Full News

Latest News

Which Factors Affect Heart Health in Indigenous Canadians?

Unconventional research highlights the need for models of cardiac care that combine Indigenous and Western knowledge systems.

Alcohol-Induced Deaths: Australian Experts Call for Support

Deaths from alcohol show no sign of declining, and some experts are calling for stronger regulation of alcohol advertising and more specialist services to meet demand.

Patients on GLP-1s: Drugs Aren’t a ‘Magic Bullet’

GLP-1s aren’t a miracle weight-loss solution but a tool that facilitates behavior change and that comes with some significant downsides, the drugs’ users tell researchers.

Can AI Match Physicians’ Judgment, Not Just Diagnosis?

Studies show that AI increasingly matches or exceeds physicians on select diagnostic tasks, yet experts stress that clinical judgment remains essential.

Low Lp(a) Not Linked to Most Safety Risks in ASCVD Patients

Low levels of lipoprotein(a) are not linked to most safety risks, except for a modest increase in the risk for diabetes, a study finds.

Does Lenvatinib Plus Nivolumab Extend Survival in HCC?

The combination of lenvatinib and nivolumab may enhance survival outcomes in patients with unresectable advanced hepatocellular carcinoma, a single-arm trial reports.

Todays Updates

Inside the Major Findings From the NHS-Galleri Trial

The largest randomized study of a multicancer blood test found no reduction in late-stage cancers, while raising new questions about stage shift, mortality benefit, and population screening.

Talquetamab Combos Show Survival Benefit in r/r Myeloma

Interim findings from the phase 3 MonumenTAL-3 trial highlight overall and progression-free survival as well as response rates compared with standard therapy.

Todays Updates

Inside the Major Findings From the NHS-Galleri Trial

The largest randomized study of a multicancer blood test found no reduction in late-stage cancers, while raising new questions about stage shift, mortality benefit, and population screening.

Talquetamab Combos Show Survival Benefit in r/r Myeloma

Interim findings from the phase 3 MonumenTAL-3 trial highlight overall and progression-free survival as well as response rates compared with standard therapy.

Latest News

Unconventional research highlights the need for models of cardiac care that combine Indigenous and Western knowledge systems.

Deaths from alcohol show no sign of declining, and some experts are calling for stronger regulation of alcohol advertising and more specialist services to meet demand.

GLP-1s aren’t a miracle weight-loss solution but a tool that facilitates behavior change and that comes with some significant downsides, the drugs’ users tell researchers.

Studies show that AI increasingly matches or exceeds physicians on select diagnostic tasks, yet experts stress that clinical judgment remains essential.

Low levels of lipoprotein(a) are not linked to most safety risks, except for a modest increase in the risk for diabetes, a study finds.

The combination of lenvatinib and nivolumab may enhance survival outcomes in patients with unresectable advanced hepatocellular carcinoma, a single-arm trial reports.

News All Time

Psoriasis Workup Expanding Beyond the Skin and Joints

The risk of some psoriasis-associated pathologies, such as cardiovascular disease, are better recognized than others.

What Is the Celebrity Effect? When Awareness Drives Action

From cancer to Parkinson's disease, public figures shape health perceptions in ways that few traditional awareness campaigns can achieve.

Exosomes Move Into the Regenerative Medicine Spotlight

Exosomes emerge as a potential alternative to stem cells in regenerative medicine, and early studies suggest roles in skin rejuvenation, alopecia, and wound healing.

DAPT for 1 Month Tied to Lower Risk for NACE

Dual antiplatelet therapy for 1 month is tied to a lower risk for NACE after stent placement, with a greater drop in bleeding than increase in the risk for MI seen with longer use.

Early Semaglutide After Bariatric Surgery Improves Outcomes

A prospective study finds that semaglutide initiated 1 month after sleeve gastrectomy is associated with greater weight loss at 1 year than surgery alone.

Ultraprocessing May Not Be ‘Inherently Harmful’

Randomized controlled trials provide ‘weak support’ for the idea that ultraprocessed foods are ‘inherently harmful’ simply because they are ultraprocessed.

Waist Size and Muscle Mass: Predictors of Prognosis in CKD

In patients with CKD, lower muscle mass is linked to higher mortality and CKD progression, and higher visceral adiposity is linked to an increased risk for cardiovascular events, a recent study finds.

Groups Urge Delay to NHS Workforce Plan

NHS leaders have called for a pause to the workforce plan, warning it underestimates staffing needs and overstates AI benefits.

CagriSema Boosts Weight Loss, A1c Benefits in T2D

The novel combination of the two therapies shows improved effects vs either drug alone, without increases in side effects.

Heat-Related CVD Burden May Nearly Triple by 2050

Rising temperatures are projected to nearly triple the burden of cardiovascular disease in the US by 2050 under a scenario of high emissions of greenhouse gases, a study estimates.

Stroke Treatment Outcomes Vary by Cancer Subtype

Patients with cancer who suffer an acute ischaemic stroke face higher odds of in-hospital death and bleeding after recanalisation therapy, with outcomes varying by cancer subtypes.

Lung Ultrasound Plus CRP May Guide Antibiotic Decisions

Lung ultrasound may help identify a bacterial component in children with acute lower respiratory tract infections and may guide antibiotic decisions when paired with C-reactive protein.

Semaglutide Accepted in Scotland for CV Risk Reduction

The SMC accepted semaglutide for adults with established cardiovascular disease and overweight or obesity, expanding its role beyond weight management.

Serum Potassium Concentrations Shape Heart Failure Risk

A meta-analysis identifies the optimal serum potassium range linked to a lower risk for death and hospitalisation in heart failure, with low potassium tied to worse outcomes in HFrEF.

Could the Iran Conflict Disrupt MRI Services?

Strikes on Qatar's gas facilities have cut global helium supply, raising concerns for hospitals running older MRI scanners.

Common Metabolic Issue in Women Tied to Mortality Risk

Women with polyendocrine metabolic ovarian syndrome face a higher risk for all-cause mortality than those without the condition, a Finnish study shows.

Recommended News For You

Preoperative MRI is useful for identifying additional disease in breast cancer patients with nodes positive.

For the creation of cutting-edge targeted radionuclide therapies in oncology, Bayer and Bicycle Therapeutics work together.

Pivotal Studies in Double-Expressor DLBCL Yield Divergent Results

Researchers found that patients undergoing chemotherapy had a higher risk of mixed infections and should begin antibiotic therapy right away.

Researchers investigate risk of developing multiple primary cancers after surviving bowel cancer

Mezigdomide Combinations Show Promise in Multiple Myeloma

ASCO: GLP-1 receptor agonists may reduce risk for obesity-related cancer, all-cause death

Recommended Articles For You

The Latest Research on Basal Cell Carcinoma: New Developments in Diagnosis and Cure  

Improving TIVAP Use: Review of Standardization and Optimization Practices 

Harnessing Artificial Intelligence in Oncology: Innovations in Diagnosis, Treatment, and Patient Care 

Understanding Acute Intermittent Porphyria: Symptoms, Diagnosis and Treatment 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

What Could This Exploratory 5-Year Survival Data in Adjuvant NSCLC Treatment Mean?

2.

FDA Approves Monthly Dosing of Rybrevant Faspro for NSCLC

3.

Capivasertib Wins Metastatic Prostate Cancer Approval

4.

A healthier lifestyle after bowel screening shown to prevent bowel cancer

5.

Worse Outcomes After Esophagectomy at Private Equity-Owned Hospitals

1.

Transformative Insights in Oncology in Daily Practice

2.

Thyroidectomy & Survival: Highlights from ASCO 2025 and Current U.S. Findings

3.

Neoadjuvant Radiotherapy & Endocrine Therapy in ER+ Breast Cancer Treatment

4.

Predicting Incidental Prostate Cancer in BPH Surgery Patients

5.

Exploring the Potential of Cytologic Atypia in Cancer Diagnosis

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Newer Immunotherapies for Myeloma- A Comprehensive Overview- Part II

2.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

3.

Current Cancer Scenario in India- Importance of Genomic Testing & Advancement in Diagnosis and Treatment

4.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part III

5.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot